FDA recall record

Italian Gluten Free Foods CL 15 oz recall — FDA F-2246-2017

Product contains undeclared eggs

Class Iclassification
F-2246-2017official record ID
May 31, 2017report date

Recall record at a glance

Official recordF-2246-2017
CategoryFood Recalls
ClassificationClass I
FDA record statusTerminated
Recalling firmItalian Gluten Free Foods CL
Report dateMay 31, 2017
Recall initiation dateMay 12, 2017
Quantity135 cases (6/per case)
LocationMerrick, NY, United States

Official product description

Chef Luca's Italian Gluten Free Foods Lasagna Al Forno Baked Cheese Lasagna, 15 oz . frozen UPC Code: 85573103116

Why the product was recalled

Product contains undeclared eggs

Distribution information

MA, CT, NY, NJ, VA, DE, MD, P A, TX

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.